Abstract
The risk of cardiac device infection (CDI) is rising significantly, with several risk factors identified. The purpose of this study is to determine the rate of CDI at our center and to assess the associated risk factors, in order to define appropriate measures to prevent this complication. We retrospectively reviewed all cases of patients with CDI at St. George Hospital between February 1999 and July 2010. Each case was matched with three controls. We performed a descriptive and bivariate analysis to identify significant risk factors. Eighteen case patients and 54 control subjects met the inclusion criteria. An organism was recovered in 58 % of the cases. Significant risk factors included previous history of CDI (p < 0.001), recent manipulation (p < 0.001), trauma to the site of implant (p = 0.003), having a dual chamber/dual lead pacemaker (p = 0.002), and development of post-procedural hematoma (p = 0.012). Our findings complement the results of previous studies. We recommend a pre-procedural risk assessment and a thorough post-implantation follow-up to prevent the development of infective complications.
Similar content being viewed by others
References
Bloom H et al (2006) Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 29(2):142–145
Epstein AE et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51(21):e1–e62
Chua JD et al (2000) Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 133(8):604–608
Sohail MR et al (2011) Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med 171(20):1821–1828
Uslan DZ et al (2007) Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 167(7):669–675
Lai KK, Fontecchio SA (1998) Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin Infect Dis 27(2):265–269
Voigt A, Shalaby A, Saba S (2010) Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol 33(4):414–419
Sohail MR et al (2007) Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 45(2):166–173
Johansen JB et al (2011) Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 32(8):991–998
Baddour LM et al (2003) Nonvalvular cardiovascular device-related infections. Circulation 108(16):2015–2031
Durack DT, Lukes AS, Bright DK (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96(3):200–209
Wiegand UK et al (2004) Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 126(4):1177–1186
Klug D et al (2007) Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116(12):1349–1355
Takahashi T et al (2002) High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. Circ J 66(8):746–750
Kutinsky IB et al (2010) Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 3(4):312–318
Costea A et al (2008) Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol 19(3):266–269
Gould PA, Krahn AD (2006) Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 295(16):1907
Kapa S et al (2007) Complication risk with pulse generator change: implications when reacting to a device advisory or recall. Pacing Clin Electrophysiol 30(6):730–733
Curtis AB, Ellenbogen KA, Hammill SC, Hayes DL, Reynolds DW, Wilber DJ, Cain ME (2004) Heart Rhythm Society Clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. Heart Rhythm 1(3):371–375
Chauhan A et al (1994) Early complications after dual chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol 17(11):2012–2015
Nery PB et al (2010) Device–related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol 21(7):786–790
Margey R et al (2010) Contemporary management of and outcomes from cardiac device related infections. Europace 12(1):64
Howarth DM, Curteis PG, Gibson S (1998) Infected cardiac pacemaker wires demonstrated by Tc-99 m labeled white blood cell scintigraphy. Clin Nucl Med 23(2):74
Dasgupta A et al (2007) Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 49(5):656–663
Greenspon AJ et al (2011) 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008. J Am Coll Cardiol 58(10):1001–1006
Le KY et al (2011) Clinical predictors of cardiovascular implantable electronic device–related infective endocarditis. Pacing Clin Electrophysiol 34(4):450–459
Parsonnet V, Bernstein AD, Lindsay B (1989) Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol 13(4):917–921
Al-Khatib SM et al (2005) The relation between patients’ outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 46(8):1536–1540
Remmelts HH et al (2009) Infection after ICD implantation: operating room versus cardiac catheterisation laboratory. Neth Heart J 17(3):95–100
Glieca F et al (1987) The role of antibiotic prophylaxis in the implantation of pacemakers. Minerva Cardioangiol 35(10):549–552
Acknowledgments
We would like to thank Dr. Brian Page for his help in formatting the tables, and Dr. Elie Akl for his help in revising the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Raad, D., Irani, J., Akl, E.G. et al. Implantable electrophysiologic cardiac device infections: a risk factor analysis. Eur J Clin Microbiol Infect Dis 31, 3015–3021 (2012). https://doi.org/10.1007/s10096-012-1655-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-012-1655-1